Company news

ZYUS Life Sciences Corporation news in 2025

ZYUS Life Sciences Corporation's news releases, calls and decks from 2025, newest first.

View company

ZYUS Life Sciences Provides Update on Clinical Trial Progress and Unit Private Placement

December 8, 2025

ZYUS Life Sciences Announces Grant of Stock Options and Deferred Share Units

December 1, 2025

ZYUS Life Sciences Corporation Announces Closing of First Tranche of Unit Offering and Issuance of Warrants Pursuant to Previously Announced Loan Agreements and Promissory Note Amendment

November 7, 2025

ZYUS Life Sciences Corporation Announces Closing of Additional Secured Loan

October 20, 2025

Wayne Brownlee provides update on holdings of ZYUS Life Sciences Corporation

October 17, 2025

Brent H. Zettl provides update on holdings of ZYUS Life Sciences Corporation

October 17, 2025

ZYUS Life Sciences Corporation Announces Closing of Secured Loan and Amendments to Prior Secured Promissory Note

October 17, 2025

ZYUS Life Sciences Announces Activation of Two Additional Clinical Sites in Phase 2a UTOPIA-1 Cancer Pain Trial

October 2, 2025

ZYUS Life Sciences Activates First Clinical Site and Enrolls First Patient in Phase 2a UTOPIA-1 Cancer Pain Trial

August 26, 2025

ZYUS Life Sciences Announces Closing of Second Tranche of Unit Offering

August 15, 2025

ZYUS Life Sciences Announces Closing of First Tranche of Unit Offering

July 29, 2025

ZYUS Life Sciences Strengthens Clinical Leadership with Appointment of Chief Medical Officer to Support Phase 2 Oncology Pain Trial

July 15, 2025

Brent H. Zettl Provides Update on Holdings of ZYUS Life Sciences Corporation

June 27, 2025

ZYUS Life Sciences Announces Closing of Unit Offering

June 27, 2025

ZYUS Life Sciences Announces Closing of First Tranche of Unit Offering

June 16, 2025

ZYUS Life Sciences Finalizing Site Initiation for Phase 2A Clinical Trial Advancing Novel Non-Opioid Pain Drug

May 22, 2025

ZYUS Life Sciences Further Expands Global Intellectual Property Portfolio with Issuance of EU Patent covering Trichomylin® Formulation and Announces Unit Offering

May 1, 2025

ZYUS Life Sciences Corporation Announces Issuance of Bonus Warrants Pursuant to Loan Agreements

April 11, 2025

ZYUS Life Sciences Corporation Announces Assumption and Amendment of Promissory Note

March 17, 2025

ZYUS Life Sciences Corporation Announces Close of Unsecured Loan and Amendment to Prior Unsecured Loans

March 10, 2025